Fibrosis, or tissue scarring, develops as a pathological deviation from the physiological
wound healing response and can occur in various organs such as the heart, lung, liver …

Myofibroblasts are contractile, α-smooth muscle actin-positive cells with multiple roles in
pathophysiological processes. Myofibroblasts mediate wound contractions, but their …

Pulmonary fibrosis is a chronic debilitating condition characterized by progressive
deposition of connective tissue, leading to a steady restriction of lung elasticity, a decline in …

Radiation-induced lung injury (RILI) is one of the main dose-limiting side effects in patients
with thoracic cancer during radiotherapy. No reliable predictors or accurate risk models are …

Idiopathic pulmonary fibrosis is a progressive scarring disease characterized by
extracellular matrix accumulation and altered mechanical properties of lung tissue. Recent …

Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic disease of unknown origin
characterized by progressive scarring of the lung leading to irreversible loss of function …

Pansclerotic morphea (PSM) is a rare, devastating disease characterized by extensive soft
tissue fibrosis, secondary contractions, and significant morbidity. PSM pathogenesis is …

Pulmonary fibrosis is a chronic and progressive lung disease characterized by the
accumulation of scar tissue in the lungs, which leads to impaired lung function and reduced …

Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …

Communication between neighboring or distant cells is made through a complex network
that includes extracellular vesicles (EVs). Exosomes, which are a subgroup of EVs, are …